PremiumThe FlyProtara Therapeutics initiated with an Outperform at Scotiabank Protara Therapeutics appoints Leonardo Viana Nicacio as chief medical officer Protara Therapeutics’ TARA-002 Shows Promising Potential in NMIBC Treatment, Justifying Buy Rating PremiumRatingsProtara Therapeutics’ TARA-002 Shows Promising Efficacy and Safety in HR-NMIBC, Earning Buy Rating Protara Therapeutics Reports Progress and Financial Results Protara Therapeutics reports Q4 EPS (48c) vs (90c) last year PremiumThe FlyLargest borrow rate increases among liquid names Largest borrow rate increases among liquid names Largest borrow rate increases among liquid names 
